Discontinuation of antihypertensive drugs due to adverse events: A systematic review and meta-analysis

Pharmacotherapy

Volumn 21, Issue 8, 2001, Pages 940-953

  Ross, Susan D ^a   Akhras, Kasem S ^a   Zhang, Shuhuan ^a   Rozinsky, Michael ^a   Nalysnyk, Luba ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; PLACEBO;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; VERTIGO;

ANTIHYPERTENSIVE AGENTS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034888870     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.11.940.34520     Document Type: Review

References (10)

1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
3. Systematic reviews: Synthesis of best evidence for clinical decisions
4. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
5. Statistical aspects of the analysis of data from retrospective studies of disease
6. Meta-analysis in clinical trials
7. On estimating the relation between blood group and disease
8. Users' guides to the medical literature. XIX. Applying clinical trial results. B. Guidelines for determining whether a drug is exerting (more than) a class effect
9. Can it work? does it work? is it worth it?